10-Q: Vireo Growth Reports Soaring Revenue Amidst Strategic Acquisitions

Vireo Growth Inc. announced a significant revenue surge in Q2 2025, driven by recent strategic acquisitions, despite a widening net loss and declining gross margins.

Summary

• Revenue for the three months ended June 30, 2025, increased by 91% to $48.06 million, up from $25.11 million in the same period last year.
• Retail revenue grew 77% to $36.77 million, and wholesale revenue surged 163% to $11.29 million for the three months ended June 30, 2025.
• The company completed three all-share merger agreements with Deep Roots Holdings, Inc., Proper Holdings, LLC, and WholesomeCo, Inc. during Q2 2025, significantly expanding its footprint into Utah, Nevada, and Missouri.
• Gross profit for the three months ended June 30, 2025, was $20.42 million, but the gross margin decreased to 42% from 54% in the prior year, primarily due to non-cash inventory fair value step-up amortization.
• Net loss for the three months ended June 30, 2025, widened significantly to $14.93 million, compared to a net loss of $0.67 million in the prior year period.
• Operating expenses increased substantially to $22.44 million from $7.76 million, driven by transaction-related expenses and higher stock-based compensation due to the mergers.
• Net cash used in operating activities for the six months ended June 30, 2025, increased to $8.15 million from $1.20 million in the prior year.
• Total assets increased to $659.34 million as of June 30, 2025, from $278.86 million at December 31, 2024, largely due to the acquired assets from the mergers.
• Total stockholders' equity increased to $268.58 million as of June 30, 2025, from $55.56 million at December 31, 2024.

Sentiment

Score: 4

Explanation: While revenue growth is strong due to acquisitions, the significant increase in net loss, declining gross margins, and worsening operating cash flow indicate operational challenges. The substantial new debt, while addressing immediate liquidity, adds to the financial burden. The ongoing litigation and federal illegality of cannabis add considerable uncertainty and risk.

Positives

• Significant revenue growth of 91% for the quarter and 48% for the six months, driven by strategic acquisitions.
• Successful completion of three major all-share merger agreements (Deep Roots, Proper, WholesomeCo), expanding market presence to Utah, Nevada, and Missouri.
• Pro forma Adjusted EBITDA for the three months ended June 30, 2025, was $23.20 million, indicating strong operational performance when accounting for non-cash and one-time items related to acquisitions.
• Improved cash position with cash increasing to $99.13 million as of June 30, 2025, from $91.60 million at December 31, 2024.
• Successful refinancing of existing senior secured debt and convertible notes with new, larger debt facilities post-period end, improving liquidity and extending maturities.

Negatives

• Net loss significantly widened to $14.93 million for the quarter and $21.44 million for the six months ended June 30, 2025.
• Gross margin decreased to 42% from 54% in the prior year quarter, primarily due to non-cash inventory fair value step-up amortization.
• Operating expenses increased substantially due to transaction-related expenses from mergers and higher stock-based compensation.
• Net cash used in operating activities worsened, increasing to $8.15 million for the six months ended June 30, 2025.
• The company continues to incur pre-tax operating losses from its New York business, which is classified as held for sale.

Risks

• The U.S. federal classification of marijuana as a Schedule I drug creates ongoing legal and regulatory risks, including potential federal enforcement and challenges in accessing financial services.
• Uncertainty regarding the timing and outcome of the $860.9 million litigation against Verano Holdings Corp. for breach of contract, which could have a significant financial impact.
• Expectation of gradual price compression as cannabis markets mature, potentially placing downward pressure on retail and wholesale gross margins.
• Exposure to interest rate risk due to variable interest-bearing debt, where a 100 basis point change could impact net loss by $384,000 per quarter.
• Significant uncertain tax liabilities totaling $75.85 million as of June 30, 2025, which could result in future cash outflows.
• Contingent consideration and clawback provisions in merger agreements introduce future financial uncertainty based on acquired companies' performance and stock price.

Future Outlook

The company anticipates future operations to benefit from increased revenue growth due to higher demand, increased product output, and new product development. However, it expects gradual price compression as markets mature, which could place downward pressure on retail and wholesale gross margins. Management expects general and administrative expenses as a percentage of sales to decrease with revenue growth, both organically and through anticipated positive regulatory developments.

Management Comments

• Management believes current production capacity has not been fully realized and expects future operations to benefit from increased revenue growth reflective of higher demand, increased product output and new product development.
• Management expects gradual price compression as markets mature, which could place downward pressure on retail and wholesale gross margins.
• Management expects general and administrative expenses as a percentage of sales to decrease as the company realizes revenue growth both organically and through anticipated positive regulatory developments in core markets.

Industry Context

Vireo Growth operates in the complex U.S. cannabis industry, characterized by rapid state-level legalization but ongoing federal illegality. This dual legal framework creates unique challenges, including limited access to traditional banking and capital, and significant tax burdens (e.g., IRS Section 280E). The company's strategy of aggressive expansion through acquisitions (Deep Roots, Proper, WholesomeCo) aligns with a broader industry trend of consolidation among multi-state operators (MSOs) seeking economies of scale and market share in limited-license states. The decline in gross margin, even with the explanation of non-cash amortization, reflects the competitive pressures and potential price compression noted by management, a common theme in maturing cannabis markets. The substantial debt refinancing indicates the continued reliance on alternative financing sources given federal restrictions on traditional banking for cannabis businesses.

Comparison to Industry Standards

• Vireo Growth's Q2 2025 gross margin of 42% (or 51% excluding non-cash amortization) is lower than some established MSOs like Green Thumb Industries (GTII) or Curaleaf (CURA), which often report gross margins in the 45-55% range, indicating potential efficiency gaps or higher cost structures, or the impact of acquisition-related accounting adjustments.
• The significant increase in net loss despite strong revenue growth suggests challenges in achieving profitability at scale, a common hurdle for many rapidly expanding cannabis companies that prioritize market penetration over immediate bottom-line results.
• The company's strategy of acquiring businesses in limited-license states (Utah, Nevada, Missouri) is a standard approach for U.S. MSOs to secure market access and build a diversified portfolio, similar to strategies employed by Trulieve Cannabis Corp. (TRUL) or Cresco Labs (CL).

Legal Proceedings

• Vireo Growth commenced an action in the Supreme Court of British Columbia against Verano Holdings Corp. on October 21, 2022, seeking $860.9 million in damages for breach of contract and breach of duty of good faith and honest performance related to a repudiated Arrangement Agreement.
• On May 2, 2024, the company filed a Notice of Application for summary determination in the Verano litigation.
• On June 19, 2024, Verano filed a Notice of Application seeking orders dismissing the Summary Trial Application, arguing certain issues are not suitable for summary determination.
• Verano filed counterclaims against the company for a $14.875 million termination fee and transaction expenses.

Related Party Transactions

• The company assumed a lease of property in Missouri owned by employees of Proper (now company members), with lease payments of $15,167 per month.
• The company assumed a lease of property in Grantsville, Utah owned by Wholesome employees (now company members), with lease payments of approximately $71,397 per month.
• The company acquired $1,000,000 of promissory notes bearing a 13% interest rate due to current employees in connection with the Wholesome Merger, which were repaid in full on July 7, 2025.
• John Mazarakis, Vireo Growth's CEO, is a partner of Chicago Atlantic Group, LP, an affiliate of Chicago Atlantic Admin, which is a significant lender to the company.

Stakeholder Impact

• Shareholders face increased dilution from the all-share merger transactions and potential future dilution from convertible debt and earn-out provisions.
• Employees of acquired entities are integrated into Vireo Growth, potentially leading to synergies or restructuring.
• Customers benefit from expanded retail presence in new states (Utah, Nevada, Missouri) and potentially a broader product offering.
• Creditors (especially Chicago Atlantic) have significant exposure to the company's debt, with new financing agreements restructuring and extending maturities.
• The ongoing Verano litigation could significantly impact shareholder value, either positively if damages are awarded or negatively if the case is lost or prolonged.

Next Steps

• Continue efforts to divest New York operations by the extended deadline of July 31, 2025.
• Manage and integrate the recently acquired Deep Roots, Proper, and WholesomeCo businesses to realize expected synergies and economies of scale.
• Address the Verano litigation, with a summary trial application pending and a preliminary suitability application from Verano to dismiss it.
• Make quarterly amortization payments on the new First Lien Term Loan starting December 31, 2025.
• Make monthly amortization payments on the Chicago Atlantic Term Loan starting November 30, 2025.
• Monitor and manage contingent consideration and clawback provisions related to the recent acquisitions, which are tied to 2026 Adjusted EBITDA performance and market share.

Key Dates

Recommendation

Vireo Growth is undergoing a significant transformation, marked by aggressive expansion through acquisitions that have substantially boosted revenue and asset base. However, this growth comes at a cost, as evidenced by widening net losses and increased cash burn from operations. The recent debt refinancing provides crucial liquidity and extends maturities, but it also increases the company's leverage. The ongoing, high-stakes litigation with Verano introduces a major element of uncertainty, with potential for both significant upside and downside. Given the mixed financial performance, the high-risk nature of the cannabis industry due to federal illegality, and the pending legal outcome, a 'hold' recommendation is appropriate. Investors should monitor the integration of acquired assets, progress in the Verano litigation, and the company's path to profitability and positive operating cash flow.

Keywords

Cannabis, SEC Filing, 10-Q, Quarterly Report, Financial Results, Acquisitions, Mergers, Revenue Growth, Net Loss, Gross Margin, Debt Refinancing, Litigation, Risk Factors, Marijuana, Multi-State Operator